ETHYL 2-(5-CHLOROPYRIDIN-2-YLAMINO)-2-OXOACETATE, 97.0%, 10g

Phosphinic acid, P-(3-aminopropyl)-P-(diethoxymethyl)-, 25mg

2-(Bromomethyl)-5-methoxypyridine hydrobromide, 95.0%, 250mg

2,3-Dichlorobenzenesulfonyl chloride, 98.0%, 25g

5-(trifluoromethyl)-1H-pyrazol-4-amine, 98+%, 5g

ethyl 6-Bromo-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate, 96%, 100mg

[1-(3-phenoxypropyl)-1H-benzimidazol-2-yl]methanol, 95.0%, 5g

Triethyl Orthobutyrate>90.0%(GC)25mL

(E)-3-(3,4-Dichlorophenyl)acrylic acid, 95.0%, 100g

4-Bromobutyronitrile>97.0%(GC)5g

Thymidine, min. 99%, pa, 25 g, glass packaging

4-(4-Oxo-2-thioxo-thiazolidin-3-yl)-benzoic acid, 95.0%, 1g

Diisobutyldiethoxysilane, 10g